There have been 4 recent insider transactions recorded for Bright Minds Biosciences Inc. (DRUG), including 3 buys and 0 sells. Total insider buying was valued at $6M and total insider selling at RSU Award.
Notable insiders with recent activity include Cormorant Asset Management, Lp. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — DRUG
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2024-11-04 |
Cormorant Asset Management, Lp |
10 Percent Owner |
Informative Buy |
184,331 |
$21.70 |
$4M |
1,059,331 |
| 2024-10-16 |
Cormorant Asset Management, Lp |
10 Percent Owner |
Informative Buy |
39,743 |
$23.22 |
$922.63K |
864,743 |
| 2024-10-15 |
Cormorant Asset Management, Lp |
10 Percent Owner |
Unknown |
- |
- |
- |
452,409 |
| 2024-10-15 |
Cormorant Asset Management, Lp |
10 Percent Owner |
Informative Buy |
238,097 |
$4.53 |
$1.08M |
690,506 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
